![Philippe Wiesel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philippe Wiesel
Chief Tech/Sci/R&D Officer at
AGOMAB THERAPEUTICS NV
Net worth: - $ as of 30/06/2026
Profile
Philippe Wiesel is the founder of Genexion SA. Currently, Dr. Wiesel is Chief Medical Officer & Executive Vice President at Calliditas Therapeutics Suisse SA since 2010 and Chief Medical Officer at AgomAb Therapeutics NV since 2021.
Formerly, Dr. Wiesel was Medical Director at EMD Serono, Inc., Serono SA, and Serono International SA, and Clinical Development Advisor at Funxional Therapeutics Ltd. Dr. Wiesel earned a doctorate from the University of Lausanne in 1993.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 18/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Philippe Wiesel active positions
| Companies | Position | Start |
|---|---|---|
| AGOMAB THERAPEUTICS NV | Chief Tech/Sci/R&D Officer | 01/01/2021 |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Chief Tech/Sci/R&D Officer | 26/05/2011 |
Former positions of Philippe Wiesel
| Companies | Position | End |
|---|---|---|
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Chief Tech/Sci/R&D Officer | - |
Serono International SA | Chief Tech/Sci/R&D Officer | - |
Genexion SA | Founder | - |
Serono SA
 Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Chief Tech/Sci/R&D Officer | - |
Funxional Therapeutics Ltd.
 Funxional Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides drug and therapeutical development services | Corporate Officer/Principal | - |
Training of Philippe Wiesel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
34
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Health Technology |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
University of Lausanne
 University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Funxional Therapeutics Ltd.
Funxional Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides drug and therapeutical development services | Health Technology |
Serono International SA | |
Genexion SA | |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues | Health Technology |
- Stock Market
- Insiders
- Philippe Wiesel
